Export 257 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
H. X. Chen, Gore-Langton, R. E., and Cheson, B. D., “Clinical trails referral resource. Current clinical trials of the anti-VEGF monoclonal antibody bevacizumab”, Oncology, vol. 15, pp. 1026-36, 2001.
A. Chen, Martz, K., Kershaw, D., Magee, J., and Panduranga, R., “Mortality Risk in Children after Renal Allograft Failure: A NAPRTCS Study”, Pediatr Nephrol, vol. 25, pp. 2517-2522, 2010.
G. Chen, Li, J., Ying, Q., Sherman, S., Perkins, N., Sundaram, R., and Mendola, P., “Evaluation of observation-fused regional air quality model results for population air pollution exposure estimation.”, Sci Total Environ, vol. 485-486, pp. 563-574, 2014.
A. Chen, Martz, K., Kershaw, D., Magee, J., and Rao, P. S., “Mortality risk in children after renal allograft failure: a NAPRTCS study.”, Pediatr Nephrol, vol. 25, no. 12, pp. 2517-22, 2010.
A. Chen, Martz, K., and Rao, P. S., “Does allograft failure impact infection risk on peritoneal dialysis: a North American Pediatric Renal Trials and Collaborative Studies Study.”, Clin J Am Soc Nephrol, vol. 7, no. 1, pp. 153-7, 2012.
A. Chen, Martz, K., and Rao, P., “Does Allograft Failure Impact Infection Risk on Peritoneal Dialysis: A North American Pediatric Renal Trials and Collaborative Studies Study”, Clin J Am Soc Nephrol, vol. 7, pp. 153-157, 2012.
H. X. Chen, Mooney, M., Boron, M., Vena, D., Mosby, K., Grochow, L., Jaffe, C., Rubinstein, L., Zwiebel, J., and Kaplan, R. S., “Phase II multicenter trial of bevacizumab plus fluorouracil and leucovorin in patients with advanced refractory colorectal cancer: an NCI Treatment Referral Center Trial TRC-0301.”, J Clin Oncol, vol. 24, no. 21, pp. 3354-60, 2006.
G. Chen, Li, J., Ying, Q., Sherman, S., Perkins, N., Rajeshwari, S., and Mendola, P. ;, “Evaluation of Observation-Fused Regional Air Quality Model Results for Population Air Pollution Exposure Estimation”, Sci Total Environ, vol. 485-486, pp. 563-574, 2014.
M. Chehade, Jones, S. M., Pesek, R. D., A Burks, W., Vickery, B. P., Wood, R. A., Leung, D. Y. M., Furuta, G. T., Fleischer, D. M., Henning, A. K., Dawson, P., Lindblad, R. W., Sicherer, S. H., J Abonia, P., Sherrill, J. D., Sampson, H. A., and Rothenberg, M. E., “Phenotypic Characterization of Eosinophilic Esophagitis in a Large Multicenter Patient Population from the Consortium for Food Allergy Research.”, J Allergy Clin Immunol Pract, vol. 6, no. 5, pp. 1534-1544.e5, 2018.
B. M. Chavers, Sullivan, E. K., Tejani, A., and Harmon, W. E., “Pre-transplant blood transfusion and renal allograft outcome: a report of the North American Pediatric Renal Transplant Cooperative Study.”, Pediatr Transplant, vol. 1, no. 1, pp. 22-8, 1997.
K. - C. Chang, Der Wang, J. -, Saxon, A., Matthews, A. G., Woody, G., and Hser, Y. - I., “Causes of death and expected years of life lost among treated opioid-dependent individuals in the United States and Taiwan.”, Int J Drug Policy, vol. 43, pp. 1-6, 2017.
L. Chang, Dowd, K., Mendoza, F., Saunders, J., Sitar, S., Plummer, S., Yamshchikov, G., Sarwar, U., Hu, Z., Enama, M., Bailer, R., Koup, R., Schwartz, R., Akahata, W., Nabel, G., Mascola, J., Pierson, T., Graham, B., Ledgerwood, J., and Team, T. V. R. C. 311 St, “Safety and Tolerability of Chikungunya Virus-Like Particle Vaccine in Healthy Adults: A Phase 1 Dose-Escalation Trial”, Lancet, vol. 384, pp. 2046-2052, 2014.
J. R. Chang, Koo, E., Agrón, E., Hallak, J., Clemons, T., Azar, D., Sperduto, R. D., Ferris, F. L., and Chew, E. Y., “Risk factors associated with incident cataracts and cataract surgery in the Age-related Eye Disease Study (AREDS): AREDS report number 32.”, Ophthalmology, vol. 118, no. 11, pp. 2113-9, 2011.
Y. - H. Chang, Duong, D. M., Goll, J. B., Wood, D. C., Jensen, T. L., Yin, L., Gelber, C. E., Seyfried, N. T., Anderson, E., Natrajan, M. S., Rouphael, N., Johnson, R. A., Sanz, P., Mulligan, M. J., and Hoft, D. F., “Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine.”, Vaccines (Basel), vol. 8, no. 3, 2020.
J. Chang, Clemons, T., Sangiovanni, J., Agron, E., and Chew, E., “Demographic and Dietary Characteristics of the Age-Related Eye Disease Study 2 (AREDS2) Participants and Their Associations With Age-Related Macular Degeneration (AMD)”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2010.
L. - J. Chang, Dowd, K. A., Mendoza, F. H., Saunders, J. G., Sitar, S., Plummer, S. H., Yamshchikov, G., Sarwar, U. N., Hu, Z., Enama, M. E., Bailer, R. T., Koup, R. A., Schwartz, R. M., Akahata, W., Nabel, G. J., Mascola, J. R., Pierson, T. C., Graham, B. S., and Ledgerwood, J. E., “Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial.”, Lancet, vol. 384, no. 9959, pp. 2046-52, 2014.
C. K. Chan, Ip, M. S., VanVeldhuisen, P. C., Oden, N. L., Scott, I. U., Tolentino, M. J., and Blodi, B. A., “SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion.”, Ophthalmology, vol. 118, no. 7, pp. 1364-72, 2011.
C. Chan, Ip, M., Van Veldhuisen, P., Oden, N., Scott, I., Tolentino, M., and Blodi, B., “SCORE Study Report #11: Incidences of Neovascular Events in Eyes with Retinal Vein Occlusion”, Ophthalmology, vol. 118, pp. 1364-1372, 2011.
J. M. Chamberlain, Okada, P., Holsti, M., Mahajan, P., Brown, K. M., Vance, C., Gonzalez, V., Lichenstein, R., Stanley, R., Brousseau, D. C., Grubenhoff, J., Zemek, R., Johnson, D. W., Clemons, T. E., and Baren, J., “Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial.”, JAMA, vol. 311, no. 16, pp. 1652-60, 2014.
J. Chamberlain, Okada, P., Holsti, M., Mahajan, P., Brown, K., Vance, C., Gonzalez, V., Lichenstein, R., Stanley, R., Brousseau, D., Grubenhoff, J., Zemek, R., Johnson, D., Clemons, T., Baren, J., and PECARN), T. Pediatric, “Lorazepam vs Diazepam for Pediatric Status Epilepticus: A Randomized Clinical Trial”, JAMA, vol. 311, pp. 1652-1660, 2014.
S. Chakraborty, Harro, C., DeNearing, B., Bream, J., Bauers, N., Dally, L., Flores, J., Van de Verg, L., Sack, D. A., and Walker, R., “Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects.”, Clin Vaccine Immunol, vol. 23, no. 4, pp. 315-25, 2016.
S. Chakraborty, Harro, C., DeNearing, B., Brubaker, J., Connor, S., Maier, N., Dally, L., Flores, J., A Bourgeois, L., Walker, R., and Sack, D. A., “Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers.”, PLoS Negl Trop Dis, vol. 12, no. 4, p. e0006442, 2018.
I. Cebere, Dorrell, L., McShane, H., Simmons, A., McCormack, S., Schmidt, C., Smith, C., Brooks, M., Roberts, J. E., Darwin, S. C., Fast, P. E., Conlon, C., Rowland-Jones, S., McMichael, A. J., and Hanke, T., “Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers.”, Vaccine, vol. 24, no. 4, pp. 417-25, 2006.
I. Cebere, Dorrell, L., McShane, H., Simmons, A., McCormack, S., Schmidt, C., Smith, C., Brooks, M., Roberts, J. E., Darwin, S. C., Fast, P. E., Conlon, C., Rowland-Jones, S., McMichael, A. J., and Hanke, T., “Phase I Clinical Trial Safety of DNA- and Modified Virus Ankara-Vectored Human Immunodeficiency Virus Type 1 (HIV-1) Vaccines Administered Alone and in a Prime-Boost Regime to healthy HIV-1 Uninfected Volunteers”, Vaccine, vol. 24, pp. 417-425, 2006.
A. T. Catanzaro, Koup, R. A., Roederer, M., Bailer, R. T., Enama, M. E., Moodie, Z., Gu, L., Martin, J. E., Novik, L., Chakrabarti, B. K., Butman, B. T., Gall, J. G. D., C King, R., Andrews, C. A., Sheets, R., Gomez, P. L., Mascola, J. R., Nabel, G. J., and Graham, B. S., “Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector.”, J Infect Dis, vol. 194, no. 12, pp. 1638-49, 2006.